메뉴 건너뛰기
Personalized Medicine
Volumn 10, Issue 8, 2013, Pages 849-857
Towards personalized medicine in the EU: What is needed to facilitate the complex international clinical research?
Author keywords

biomarker; cancer; clinical; imaging; infrastructure; legal; personalized medicine; platform; research
Indexed keywords

CLINICAL RESEARCH; DRUG DEVELOPMENT; EUROPEAN UNION; HEALTH CARE INDUSTRY; HUMAN; LEGAL ASPECT; NEOPLASM; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW;
EID: 84886552404     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.76     Document Type: Review
Times cited : (1)
References (11)
  • 1
    • 80053238941 scopus 로고    scopus 로고
    • Delivering affordable cancer care in high-income countries
    • Sullivan R, Peppercorn J, Sikora K et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 12(10), 933-980 (2011
    • (2011) Lancet Oncol , vol.12 , Issue.10 , pp. 933-980
    • Sullivan, R.1    Peppercorn, J.2    Sikora, K.3
  • 2
    • 84866739808 scopus 로고    scopus 로고
    • Drug discovery in pharmaceutical industry: Productivity challenges and trends
    • Khanna I. Drug discovery in pharmaceutical industry: Productivity challenges and trends. Drug Discov. Today 17, 1088-1102 (2012
    • (2012) Drug Discov. Today , vol.17 , pp. 1088-1102
    • Khanna, I.1
  • 3
    • 77951705293 scopus 로고    scopus 로고
    • Has the European Clinical Trials Directive been a success?
    • Frewer LJ, Coles D, Champion K et al. Has the European Clinical Trials Directive been a success? BMJ 340, c1862 (2010
    • (2010) BMJ , vol.340
    • Frewer, L.J.1    Coles, D.2    Champion, K.3
  • 4
    • 84881084837 scopus 로고    scopus 로고
    • How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment
    • Burock F, Meunier F, Lacombe D. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment? Eur. J. Cancer 49(13), 2777-2783 (2013
    • (2013) Eur J. Cancer , vol.49 , Issue.13 , pp. 2777-2783
    • Burock, F.1    Meunier, F.2    Lacombe, D.3
  • 5
    • 61349159896 scopus 로고    scopus 로고
    • Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies
    • Kummar S, Doroshow JH, Tomaszewski JE et al. Phase 0 clinical trials: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies. Eur. J. Cancer 45(5), 741-746 (2009
    • (2009) Eur. J. Cancer , vol.45 , Issue.5 , pp. 741-746
    • Kummar, S.1    Doroshow, J.H.2    Tomaszewski, J.E.3
  • 6
    • 84874501540 scopus 로고    scopus 로고
    • Designs and challenges for personalized medicine studies in oncology: Focus on the shiva trial
    • Le Tourneau C, Kamal M, Tredan O et al. Designs and challenges for personalized medicine studies in oncology: Focus on the SHIVA trial. Target. Oncol. 7(4), 253-265 (2012
    • (2012) Target. Oncol , vol.7 , Issue.4 , pp. 253-265
    • Le Tourneau, C.1    Kamal, M.2    Tredan, O.3
  • 7
    • 84855895068 scopus 로고    scopus 로고
    • Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories
    • Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu. Rev. Pharmacol. Toxicol. 52, 275-301 (2012
    • (2012) Annu. Rev. Pharmacol. Toxicol , vol.52 , pp. 275-301
    • Blaschke, T.F.1    Osterberg, L.2    Vrijens, B.3    Urquhart, J.4
  • 8
    • 84860142228 scopus 로고    scopus 로고
    • Open clinical trial data for all? A view from regulators
    • Eichler H-G, Abadie E, Breckenridge A et al. Open clinical trial data for all? A view from regulators. PLoS Med. 9(4), e1001202 (2012
    • (2012) PLoS Med , vol.9 , Issue.4
    • Eichler, H.-G.1    Abadie, E.2    Breckenridge, A.3
  • 9
    • 84879350071 scopus 로고    scopus 로고
    • Master protocol aims to revamp cancer trials
    • Ledford H. Master protocol aims to revamp cancer trials. Nature 498(7453), 146-147 (2013
    • (2013) Nature , vol.498 , Issue.7453 , pp. 146-147
    • Ledford, H.1
  • 10
    • 84871447346 scopus 로고    scopus 로고
    • Academia-industry partnerships: Are we ready for new models of partnership? The point of view of the EORTC, an academic clinical cancer research organization
    • Lacombe D, Burock S, Meunier F. Academia-industry partnerships: Are we ready for new models of partnership? The point of view of the EORTC, an academic clinical cancer research organization. Eur. J. Cancer 49, 1-7 (2013
    • (2013) Eur. J. Cancer , vol.49 , pp. 1-7
    • Lacombe, D.1    Burock, S.2    Meunier, F.3
  • 11
    • 84857926886 scopus 로고    scopus 로고
    • Public-private partnerships need honest brokering
    • Goldman M. Public-private partnerships need honest brokering. Nat. Med. 18(3), 341 (2012
    • (2012) Nat. Med , vol.18 , Issue.3 , pp. 341
    • Goldman, M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.